Evaluation of two-point Dixon water-fat separation for liver specific contrast-enhanced assessment of liver maximum capacity
暂无分享,去创建一个
Christian Stroszczynski | Philipp Wiggermann | Michael Haimerl | Florian Zeman | Dominik Nickel | Claudia Fellner | C. Stroszczynski | P. Wiggermann | M. Haimerl | D. Nickel | C. Fellner | F. Zeman | S. Brunner | K. Weigand | Ute Probst | Stefanie Poelsterl | Kilian Weigand | Stefan M Brunner | S. Poelsterl | Ute Probst
[1] C. Stroszczynski,et al. Volume-assisted estimation of liver function based on Gd-EOB-DTPA–enhanced MR relaxometry , 2016, European Radiology.
[2] Markus Grube,et al. Hepatic Uptake of the Magnetic Resonance Imaging Contrast Agent Gd-EOB-DTPA: Role of Human Organic Anion Transporters , 2010, Drug Metabolism and Disposition.
[3] S. Qu,et al. The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD) , 2010, Lipids in Health and Disease.
[4] Meng-Su Zeng,et al. Assessing liver function in patients with HBV-related HCC: a comparison of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI , 2015, European Radiology.
[5] J. Everhart,et al. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. , 2003, Gastroenterology.
[6] A. Teufel,et al. Gd-EOB-DTPA-enhanced MRI for evaluation of liver function: Comparison between signal-intensity-based indices and T1 relaxometry , 2017, Scientific Reports.
[7] W. T. Dixon. Simple proton spectroscopic imaging. , 1984, Radiology.
[8] E. Alexopoulou,et al. Use of fat suppression in R₂ relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients. , 2012, Magnetic resonance imaging.
[9] Christian Stroszczynski,et al. Assessment of Clinical Signs of Liver Cirrhosis Using T1 Mapping on Gd-EOB-DTPA-Enhanced 3T MRI , 2013, PloS one.
[10] T. Utsunomiya,et al. Possible utility of MRI using Gd-EOB-DTPA for estimating liver functional reserve , 2012, Journal of Gastroenterology.
[11] M. D. Nickel,et al. Gd-EOB-DTPA-enhanced T1 relaxometry for assessment of liver function determined by real-time 13C-methacetin breath test , 2018, European Radiology.
[12] S. Akata,et al. Distinguishing hepatic hemangiomas from metastatic tumors using T1 mapping on gadoxetic-acid-enhanced MRI. , 2013, Magnetic resonance imaging.
[13] K. Kamimura,et al. Quantitative evaluation of liver function with T1 relaxation time index on Gd‐EOB‐DTPA‐enhanced MRI: Comparison with signal intensity‐based indices , 2014, Journal of magnetic resonance imaging : JMRI.
[14] S. Kumano,et al. Estimation of Liver Function Using T1 Mapping on Gd-EOB-DTPA-Enhanced Magnetic Resonance Imaging , 2011, Investigative radiology.
[15] M. Bock,et al. Intravascular contrast agent T1 shortening: fast T1 relaxometry in a carotid volunteer study , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.
[16] G. Glover. Multipoint dixon technique for water and fat proton and susceptibility imaging , 1991, Journal of magnetic resonance imaging : JMRI.
[17] A. Schreyer,et al. MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score , 2014, Scientific Reports.
[18] D. Seehofer,et al. How to define initial poor graft function after liver transplantation? – a new functional definition by the LiMAx test , 2010, Transplant international : official journal of the European Society for Organ Transplantation.
[19] L. Adams,et al. International Journal of Molecular Sciences the Natural Course of Non-alcoholic Fatty Liver Disease , 2022 .
[20] E. Jung,et al. Chronic liver disease: Quantitative MRI vs CEUS-based microperfusion. , 2017, Clinical hemorheology and microcirculation.
[21] T. Miyati,et al. The Dixon technique and the frequency-selective fat suppression technique in three-dimensional T1 weighted MRI of the liver: a comparison of contrast-to-noise ratios of hepatocellular carcinomas-to-liver. , 2015, The British journal of radiology.
[22] B. Thapa,et al. Liver function tests and their interpretation , 2007, Indian journal of pediatrics.
[23] S. Harrison,et al. Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection , 2010, Hepatology.
[24] E. Nagel,et al. Native Myocardial T1 Mapping by Cardiovascular Magnetic Resonance Imaging in Subclinical Cardiomyopathy in Patients With Systemic Lupus Erythematosus , 2013, Circulation. Cardiovascular imaging.
[25] Peter Kellman,et al. Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method , 2012, Journal of Cardiovascular Magnetic Resonance.
[26] Sanjeev Chawla,et al. MR‐visible lipids and the tumor microenvironment , 2011, NMR in biomedicine.
[27] P. Kellman,et al. Characterization of myocardial T1-mapping bias caused by intramyocardial fat in inversion recovery and saturation recovery techniques , 2015, Journal of Cardiovascular Magnetic Resonance.
[28] R. Lauffer,et al. Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.
[29] B. Taouli,et al. 3D T1 relaxometry pre and post gadoxetic acid injection for the assessment of liver cirrhosis and liver function. , 2015, Magnetic resonance imaging.
[30] K. Kamimura,et al. Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function , 2014, European Radiology.
[31] D. Seehofer,et al. The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. , 2010, HPB : the official journal of the International Hepato Pancreato Biliary Association.